Salarius Pharmaceuticals Inc investor relations material

Listen to the latest call from Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focuses on developing epigenetic-based cancer treatments. Salarius Pharmaceuticals, Inc. is developing a new class of DNA-targeted anticancer agents that enable the suppression of tumor growth by reversing the aberrant epigenetic changes found in cancer cells. These DNA targeted agents are produced in a fully scalable process that allows rapid scale up to meet commercial demands and enable quick entry into clinical trials.

Dig deeper into the Salarius Pharmaceuticals Inc fundamentals on Quartr.